Torii Pharmaceutical Co., Ltd.

TSE:4551 Stok Raporu

Piyasa değeri: JP¥118.7b

Torii Pharmaceutical Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Torii Pharmaceutical's earnings are forecast to decline at 1.7% per annum while its annual revenue is expected to grow at 3.9% per year. EPS is expected to decline by 1.7% per annum. Return on equity is forecast to be 4.3% in 3 years.

Anahtar bilgiler

-1.7%

Kazanç büyüme oranı

-1.7%

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi11.9%
Gelir büyüme oranı3.9%
Gelecekteki özkaynak getirisi4.3%
Analist kapsamı

Low

Son güncelleme01 Nov 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Kazanç ve Gelir Büyüme Tahminleri

TSE:4551 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (JPY Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/202671,6506,7204,745N/A2
12/31/202566,3005,9652,773N/A2
12/31/202460,6504,7402,819N/A2
9/30/202458,8395,276N/AN/AN/A
6/30/202457,2485,2541,0891,256N/A
3/31/202456,2785,285N/AN/AN/A
12/31/202354,6384,119-3,339-3,123N/A
9/30/202352,7133,456N/AN/AN/A
6/30/202351,4933,18581265N/A
3/31/202349,7472,774N/AN/AN/A
12/31/202248,8963,9442,1392,420N/A
9/30/202248,8653,992N/AN/AN/A
6/30/202248,5343,9752,0662,424N/A
3/31/202248,0483,820N/AN/AN/A
12/31/202146,9873,374-530-156N/A
9/30/202144,9653,225N/AN/AN/A
6/30/202143,3982,939-226266N/A
3/31/202142,0283,069N/AN/AN/A
12/31/202041,7003,495-3,854-3,443N/A
9/30/202041,8503,409N/AN/AN/A
6/30/202042,1712,973-12,178-11,961N/A
3/31/202043,408-293N/AN/AN/A
12/31/201942,99827,36742,08042,499N/A
9/30/201948,32825,382N/AN/AN/A
6/30/201952,68425,81053,43254,047N/A
3/31/201957,78229,117N/AN/AN/A
12/31/201862,5511,1647,7318,259N/A
9/30/201863,9524,195N/AN/AN/A
6/30/201864,5964,505N/A7,124N/A
3/31/201864,4574,899N/AN/AN/A
12/31/201764,1354,718N/A6,349N/A
9/30/201762,1643,855N/AN/AN/A
6/30/201761,2833,117N/A4,699N/A
3/31/201760,0742,424N/AN/AN/A
12/31/201660,2062,839N/A3,402N/A
9/30/201661,3052,951N/AN/AN/A
6/30/201661,9573,378N/A3,136N/A
3/31/201662,8203,798N/AN/AN/A
12/31/201562,3783,527N/A4,940N/A
12/31/201458,0893,393N/A-812N/A
9/30/201457,1073,031N/A2,013N/A
6/30/201456,5172,972N/AN/AN/A
3/31/201458,1093,352N/A-201N/A
12/31/201355,2912,335N/AN/AN/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 4551's earnings are forecast to decline over the next 3 years (-1.7% per year).

Kazançlar ve Piyasa: 4551's earnings are forecast to decline over the next 3 years (-1.7% per year).

Yüksek Büyüme Kazançları: 4551's earnings are forecast to decline over the next 3 years.

Gelir ve Pazar: 4551's revenue (3.9% per year) is forecast to grow slower than the JP market (4.2% per year).

Yüksek Büyüme Geliri: 4551's revenue (3.9% per year) is forecast to grow slower than 20% per year.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 4551's Return on Equity is forecast to be low in 3 years time (4.3%).

Büyüyen şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y